Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
RAPAMUNE Lös 1 mg/ml Fl 60 ml
Drug
Rapamune, Lösung zum Einnehmen
Immunsuppressivum
07.15.0. – immunosuppressants
HAM – Human medicine
LSOR – Oral solution
BT – biological medicines
B – Dispensed on prescription by a physician or veterinarian (B)
Z – approved
9/26/2000
12/31/9999
Dosage strength
Rapamune 1 mg/ml, Lösung zum Einnehmen
Immunsuppressivum
01
Z – approved
Package
7680552430024
In trade from / since 9/26/2000
A/R – Authorised / referenced
60 ml
002
Z – approved
Declaration
Component
1 mg sirolimusum
polysorbatum 80
phosphatidylcholinum
20 mg sojae oleum
mono/diglycerida
20 mg ethanolum 96 per centum
350 mg propylenglycolum
E 304
3.17 % V/V ethanolum
phosphatidylcholinum
20 mg sojae oleum
mono/diglycerida
20 mg ethanolum 96 per centum
350 mg propylenglycolum
E 304
3.17 % V/V ethanolum
Spezialitätenliste***
SL
-
-
279.80
None
No
10%
No
Authorisation holder
7601001010604
Pfizer AG
Schärenmoosstrasse 99
8052 Zürich (ZH)
Schärenmoosstrasse 99
8052 Zürich (ZH)
Date of revision of the text
4/29/2025
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.